antibody-drug conjugates

​​​​​Greater focus on non-animal testing methods in the UK, a new CRISPR treatment to lower cholesterol, and positive results for a BTK inhibitor in MS led the news this week.

FDA approvals, rejections, antibody-drug conjugate deals, and more led the news this week.

New funding will support scaling, team expansion, and the launch of customizable solutions for spatial biology, proteomics, and single-cell analysis.

Simtra is positioned to become the first CDMO to offer commercial-scale drug product manufacturing of ADCs in the US, enabling customers to complete the entire supply chain domestically.

Manish Sharma led a clinical trial for a new antibody-drug conjugate that decreased tumor size in patients who had not responded to chemotherapy.

Lantern Pharma kicks off ADC program to develop treatments for various cancer types